Financhill
Back

Prothena Corp. Plc 10K Form

Sell
41

PRTA
Prothena Corp. Plc

Last Price:
$11.15
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive PRTA News And Ratings

See the #1 stock for the next 7 days that we like better than PRTA

PRTA Financial Statistics

Sales & Book Value

Annual Sales: $135.2M
Cash Flow: $-43.2M
Price / Cash Flow: 0
Annual Sales: $5.48
Price / Book: 2.04

Profitability

EPS (TTM): -5.21060
Net Income (TTM): $-280.5M
Gross Margin: $131.6M
Return on Equity: -67.47%
Return on Assets: -58.69%

Prothena Corp. Plc Earnings Forecast

Key Prothena Corp. Plc Financial Ratios

  • The Gross Profit Margin over the past 15 years for PRTA is 97.35%.
  • The Selling, General & Administrative Expenses for PRTA have been equal to 49.72% of Gross Profit Margin.
  • The Research & Development expenses have been 164.64% of Revenue.
  • The Net Earning history of PRTA is -90.49% of Total Revenues.
  • Per Share Earnings over the last 15 years have been positive in 7 years.

Prothena Corp. Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: PRTA
CUSIP: G72800
Website: prothena.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 6.61
Quick Ratio: 6.43

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 21.19

PRTA Technical Analysis vs Fundamental Analysis

Sell
41
Prothena Corp. Plc (PRTA) is a Sell

Is Prothena Corp. Plc a Buy or a Sell?